158 related articles for article (PubMed ID: 36637946)
1. Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review.
Liu S; Miao M; Kang L
Medicine (Baltimore); 2023 Jan; 102(2):e32625. PubMed ID: 36637946
[TBL] [Abstract][Full Text] [Related]
2. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
3. Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis.
Chen Q; Yang S; Zhang Y; Li B; Xu H; Zuo S
Biomed Res Int; 2022; 2022():9868022. PubMed ID: 35132379
[TBL] [Abstract][Full Text] [Related]
4. ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma.
Sun Q; Liu X; Peng Q; Hu L; Jiang X
J Immunol Res; 2022; 2022():1584397. PubMed ID: 35615532
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
Wu S; Liu S; Cao Y; Chao G; Wang P; Pan H
Aging (Albany NY); 2022 Mar; 14(5):2304-2319. PubMed ID: 35278064
[TBL] [Abstract][Full Text] [Related]
6. ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
Lou W; Wang W; Chen J; Wang S; Huang Y
Mol Ther Nucleic Acids; 2021 Jun; 24():845-855. PubMed ID: 34026328
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis to identify noncoding RNAs mediated upregulation of maternal embryonic leucine zipper kinase (MELK) correlated with poor prognosis in hepatocellular carcinoma.
Guo Z; Zhu Z
Aging (Albany NY); 2022 May; 14(9):3973-3988. PubMed ID: 35511171
[TBL] [Abstract][Full Text] [Related]
8. Targeting of MAD2L1 by miR-515-5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells.
Ding X; Fu Q; Chen W; Chen L; Zeng Q; Zhang S; He L
Cell Biol Int; 2022 May; 46(5):840-848. PubMed ID: 35143103
[TBL] [Abstract][Full Text] [Related]
9. High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma.
Chen Z; Lin X; Wan Z; Xiao M; Ding C; Wan P; Li Q; Zheng S
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627262
[TBL] [Abstract][Full Text] [Related]
10. MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma.
Gao Y; Liu Y; Sun L; Ouyang X; Zhu C; Qin X
Genet Test Mol Biomarkers; 2021 Nov; 25(11):685-695. PubMed ID: 34788140
[No Abstract] [Full Text] [Related]
11. High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.
Ren Y; Qian Y; Zhang Q; Li X; Li M; Li W; Yang P; Ren H; Li H; Weng Y; Li D; Xu K; Yu W
Cancer Cell Int; 2024 Apr; 24(1):142. PubMed ID: 38643145
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
Shi YX; Zhu T; Zou T; Zhuo W; Chen YX; Huang MS; Zheng W; Wang CJ; Li X; Mao XY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Dec; 7(51):85235-85243. PubMed ID: 27835911
[TBL] [Abstract][Full Text] [Related]
13. High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma.
Mao G; Shan C; Li W; Liang B; Ma L; Zhang S
Int J Gen Med; 2022; 15():2607-2620. PubMed ID: 35282644
[TBL] [Abstract][Full Text] [Related]
14. hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration.
Tan S; Song X; Zhang C; Sun Y; Zhang J; Zhang Z; Zhang R; Zhang T; Zhu X; Tan H
J Immunol Res; 2022; 2022():9051229. PubMed ID: 35600044
[TBL] [Abstract][Full Text] [Related]
15. ncRNA-mediated upregulation of
Zou W; Wang H; Wu D; Wu Y; Zhou K; Lian Y; Chang G; Feng Y; Liang J; Huang G
Front Endocrinol (Lausanne); 2023; 14():1093042. PubMed ID: 37065746
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis.
Wang X; Wu S; Yang Y; Zhao J
Oxid Med Cell Longev; 2022; 2022():9277360. PubMed ID: 36254230
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
